Ausgabe 4/2017
Inhalt (11 Artikel)
Erythropoietin Attenuates Cardiac Dysfunction in Rats by Inhibiting Endoplasmic Reticulum Stress-Induced Diabetic Cardiomyopathy
Jing Lu, Qi-ming Dai, Gen-shan Ma, Yue-hong Zhu, Bing Chen, Bing Li, Yu-yu Yao
MDCO-216 Does Not Induce Adverse Immunostimulation, in Contrast to Its Predecessor ETC-216
Joannes A. A. Reijers, D. G. Kallend, K. E. Malone, J. W. Jukema, P. L. J. Wijngaard, J. Burggraaf, M. Moerland
The Treatment Effect of an ACE-Inhibitor Based Regimen with Perindopril in Relation to Beta-Blocker use in 29,463 Patients with Vascular Disease: a Combined Analysis of Individual Data of ADVANCE, EUROPA and PROGRESS Trials
J. J. Brugts, M. Bertrand, W. Remme, R. Ferrari, K. Fox, S. MacMahon, J. Chalmers, M. L. Simoons, E. Boersma
Does Treatment of Impaired Glucose Tolerance Improve Cardiovascular Outcomes in Patients with Previous Myocardial Infarction?
Masanori Asakura, Jiyoong Kim, Hiroshi Asanuma, Toshimitsu Hamasaki, Kengo Tsukahara, Yorihiko Higashino, Tetsuya Ishikawa, Yasuharu Nakama, Shinji Koba, Yasuyuki Maruyama, Mitsuru Tsujimoto, Hideo Himeno, Takanori Ohkusa, Susumu Fujino, Makoto Shimizu, Tsutomu Endo, Shunichi Yoda, Takahiro Muroya, Toyoaki Murohara, Nobuyuki Ohte, Hiroshi Suzuki, Tohru Kohno, Kazuki Fukui, Takaaki Shiono, Hiroyuki Takase, Hiroyasu Uzui, Yoshiyuki Nagai, Yuji Hashimoto, Shuntaro Ikeda, Sumio Mizuno, Koichi Tamita, Masashi Fujita, Kazuo Satake, Yoshihiko Kinoshita, Tatsuya Nunohiro, Satoru Sakagami, Jitsuo Higaki, Isao Morii, Reimin Sawada, Yoshikazu Hiasa, Tomohiko Shigemasa, Makoto Nakahama, Masataka Sata, Osamu Doi, Tetsuro Ueda, Takahisa Yamada, Takayoshi Yamanouchi, Hajime Yamaguchi, Yukiko Morita, Hideki Hayashi, Masafumi Kitakaze
Is Initiating NOACs for Atrial Arrhythmias Safe in Adults with Congenital Heart Disease?
Hayang Yang, Berto J. Bouma, Barbara J. M. Mulder, J.F. Heidendael, G. Veen, T.C. Konings, G.T.J. Sieswerda, F.J. Meijboom, M.C. Post, A. van Dijk, W. Budts, M. Morissens, M. Ladouceur, D. Tobler, M. Schwerzmann, T. Rutz, J. Bouchardy, M. Greutmann, G. Scognamiglio, K. Skoglund, C. Christersson, L. Gumbiene, M. Laukyte, P. Khairy, J. Aboulhosn, G. Veldtman, G. Webb, C.S. Broberg, A.R. Opotowsky, K. Shafer, S.F. Tsai, T. Moe, K. Niwa, A. Mizuno
Efficacy and Safety of Alternate-Day Versus Daily Dosing of Statins: a Systematic Review and Meta-Analysis
Kamal Awad, Dimitri P. Mikhailidis, Peter P. Toth, Steven R. Jones, Patrick Moriarty, Gregory Y. H. Lip, Paul Muntner, Alberico L. Catapano, Michael J. Pencina, Robert S. Rosenson, Jacek Rysz, Maciej Banach
The PARTHENON Clinical Development Program: the Role of Ticagrelor in Patients with Atherothrombotic Disease
Paul P. Dobesh, Manesh Patel
Navigating the Future of Cardiovascular Drug Development—Leveraging Novel Approaches to Drive Innovation and Drug Discovery: Summary of Findings from the Novel Cardiovascular Therapeutics Conference
Thomas J. Povsic, Rob Scott, Kenneth W. Mahaffey, Robert Blaustein, Jay M. Edelberg, Martin P. Lefkowitz, Scott D. Solomon, Jonathan C. Fox, Kevin E. Healy, Aarif Y. Khakoo, Douglas W. Losordo, Fady I. Malik, Brett P. Monia, Rusty L. Montgomery, Jeffrey Riesmeyer, Gregory G. Schwartz, Steven L. Zelenkofske, Joseph C. Wu, Scott M. Wasserman, Matthew T. Roe
Recent Insights into Pharmacologic Cardiovascular Risk Reduction in Type 2 Diabetes Mellitus
Scott L. Purga, Mandeep Sidhu, Michael Farkouh, Joshua Schulman-Marcus
The Pharmacogenomic and Metabolomic Predictors of ACE Inhibitor and Angiotensin II Receptor Blocker Effectiveness and Safety
Hania K. Flaten, Andrew A. Monte
Erratum to: Vasodilator Therapy: Nitrates and Nicorandil
Jason M. Tarkin, Juan Carlos Kaski